Precision’s drug delivery technologies enable routine injection to deliver drugs to specific back-of-eye tissues, including the suprachoroidal, sub-retinal and other small spaces, resulting in improved therapeutic benefits and safety.

Precision’s drug formulations are optimized to suit the unique ocular environments where they are delivered resulting in better pharmacokinetics, pharmacodynamics and desired treatment duration.

Precision’s product development pipeline includes treatments for both prevalent retinal diseases, such as age related macular degeneration and diabetic macular oedema, as well as rare and orphan indications. We are also developing specialized systems to routinely and safely deliver cell and gene therapy to specific tissues in the eye for partners.